Simultaneous integrated boost intensity-modulated radiotherapy (SIB-IMRT) combined with nimotuzumab for locally advanced esophageal squamous cell carcinoma (ESCC): A phase II clinical trialLan Wang, Chun Han, Yu Cao et al.|BMC Cancer|2024Cited by 6